These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4332671)

  • 1. Adrenal and ovarian contributions to the elevated free plasma androgen levels in hirsute women.
    Rosenfield RL; Ehrlich EN; Cleary RE
    J Clin Endocrinol Metab; 1972 Jan; 34(1):92-8. PubMed ID: 4332671
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence of excessive androgen secretion by both the ovary and the adrenal in patients with idiopathic hirsutism.
    Pugeat M; Forest MG; Nisula BC; Corniau J; De Peretti E; Tourniaire J
    Obstet Gynecol; 1982 Jan; 59(1):46-51. PubMed ID: 6804896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined dexamethasone and human chorionic gonadotropin in diagnosis of polycystic ovarian disease.
    Beck WW; McEvoy D; Wallach EE
    Obstet Gynecol; 1971 Feb; 37(2):211-7. PubMed ID: 5539356
    [No Abstract]   [Full Text] [Related]  

  • 4. Androsterone glucuronide is a marker of adrenal hyperandrogenism in hirsute women.
    Thompson DL; Horton N; Rittmaster RS
    Clin Endocrinol (Oxf); 1990 Mar; 32(3):283-92. PubMed ID: 2160872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma testosterone stimulation-suppression dynamics in hirsute women.
    Ettinger B; Von Werder K; Thenaers GC; Forsham PH
    Am J Med; 1971 Aug; 51(2):170-5. PubMed ID: 4328775
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic evaluation of hirsutism in women by selective bilateral adrenal and ovarian venous catheterization.
    Farber M; Millan VG; Turksoy RN; Mitchell GW
    Fertil Steril; 1978 Sep; 30(3):283-8. PubMed ID: 710599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of testosterone and androstenedione porduction rates with dexamethasone in women with idiopathic hirsutsm and polycystic ovaries.
    Bardin CW; Hembree WC; Lipsett MB
    J Clin Endocrinol Metab; 1968 Sep; 28(9):1300-6. PubMed ID: 4300558
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma and urinary androgens in hirsute women during adrenal and ovarian suppression.
    Aakvaag A; Vogt JH; Fylling P
    Acta Endocrinol (Copenh); 1970 May; 64(1):103-10. PubMed ID: 5468790
    [No Abstract]   [Full Text] [Related]  

  • 10. Should androgen levels be measured in hirsute women with normal menstrual cycles?
    Mehta A; Matwijiw I; Taylor PJ; Salamon EA; Kredentser JV; Faiman C
    Int J Fertil; 1992; 37(6):354-7. PubMed ID: 1360456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian and adrenal contributions to peripheral androgens in hirsute women.
    Abraham GE; Chakmakjian ZH; Buster JE; Marshall JR
    Obstet Gynecol; 1975 Aug; 46(2):169-73. PubMed ID: 125398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adrenal cortex and ovarian intervention in the pathogenesis of minor hyperandrogenism. I. Study of fractionated urinary 17-ketosteroids in basal and dynamic conditions in 30 women with hirsutism].
    Minozzi M; Faggiano M; Salerno M; Orio F; Lombardi G; Jori JP
    Folia Endocrinol; 1967 Dec; 20(6):736-64. PubMed ID: 4303786
    [No Abstract]   [Full Text] [Related]  

  • 13. 11 beta-hydroxyandrostenedione: a marker of adrenal function in hirsutism.
    Hudson RW; Lochnan HA; Danby FW; Margesson LJ; Strang BK; Kimmett SM
    Fertil Steril; 1990 Dec; 54(6):1065-71. PubMed ID: 2174005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
    Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E
    J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB; Ehrmann DA; Brigell DF; Rosenfield RL
    J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The origin of androgen synthesis in polycystic ovary syndrome.
    Milewicz A; Silber D; Mielecki T
    Obstet Gynecol; 1983 Nov; 62(5):601-4. PubMed ID: 6225965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic hirsutism--an ovarian abnormality.
    Kirschner MA; Zucker IR; Jespersen D
    N Engl J Med; 1976 Mar; 294(12):637-40. PubMed ID: 1246257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression and stimulation of plasma testosterone and DHT in hirsute women.
    Paetzmann H; Elsaesser F; Haller J; Häffele R
    Acta Endocrinol Suppl (Copenh); 1973; 173():170. PubMed ID: 4353564
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test.
    Wajchenberg BL; Achando SS; Okada H; Czeresnia CE; Peixoto S; Lima SS; Goldman J
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1204-10. PubMed ID: 3760120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dexamethasone on serum cortisol and androgen levels in hirsute patients.
    Abraham GE; Maroulis GB; Buster JE; Chang RJ; Marshall JR
    Obstet Gynecol; 1976 Apr; 47(4):395-402. PubMed ID: 130572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.